Assessment of Serum and Red Blood Cell Folate Methodology; Availability of Tentative Report; Announcement of Public Meeting

Resumo

The Food and Drug Administration (FDA) is announcing the availability of a report entitled ``Tentative Report: Assessment of Serum and Red Blood Cell Folate Methodology Used in NHANES III.'' The report was prepared for FDA by the Life Sciences Research Office (LSRO) of the Federation of American Societies for Experimental Biology (FASEB). This document also announces a public meeting on the subject of the tentative report. The announcement of this meeting and the tentative report are intended to provide FDA with scientific information on the assessment of folate status in the U.S. population.